Molecular genetic markers of pancreatic cancer in fine-needle biopsy samples
Journal of Clinical Practice · 15.11.2026 · 17 (3) · 89-98
DOI: 10.17816/clinpract707917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Practice, online erschienen am 15.11.2026. Verfasst von Tatiana L. Poloz und 6 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Interpreting the results of morphological studies of pancreatic tumours remains a challenging clinical task due to the technical difficulties involved in biopsy, the diversity of histological types of neoplasms, the relative monomorphism and small size of tumour cells, as well as the subtle signs of cytological atypia in some variants of the pathology; at the same time, early and accurate diagnosis is crucial for improving the effectiveness of treatment. The availability of effective auxiliary methods for assessing the nature of the tumour process could significantly enhance the diagnostic toolkit and improve the clarity of result interpretation. AIM: The aim of the study was to develop and determine the diagnostic characteristics of a classifier based on the profiling of microRNA (miRNA) expression and the assessment of mutation rates in the KRAS gene for the differential diagnosis of malignant and benign processes in cytological samples from patients with pancreatic neoplasms. METHODS: The study examined 186 pancreatic cytology samples, of which 67 were obtained via fine-needle aspiration biopsy of pancreatic tumours under endoscopic ultrasound guidance, as well as via pancreatic puncture biopsy during surgical intervention, and 119 pancreatic smear samples taken during post-mortem examination of patients with non-neoplastic lesions. 11 miRNAs, markers of pancreatic malignancy (miRNA-21, -221, -155, -196b, -96, -34a, -150, -375, -143, -1246, let-7a), were included into analysis, with U6 small nuclear RNA used as a reference. miRNA detection was carried out using reverse transcription real-time polymerase chain reaction (RT-qPCR). Sample stratification was performed using the C4.5 decision tree algorithm. In addition to miRNAs, all samples were analysed for the presence of the following somatic mutations: G12A, G12C, G12D, G12R, G12S, G12V, G13D and Q61K, Q61R, Q61L, Q61H in the KRAS gene. RESULTS: The decision tree included miRNAs-375, -143, -155, -96, -221, let-7a. As a result of applying the classifier to cytology samples obtained by fine-needle aspiration biopsy of pancreatic tumours, 65 samples were classified as 'pancreatic cancer' and 2 as 'non-neoplastic pancreatic lesion'. Of the 119 samples obtained from non-neoplastic tissue, 22 were classified as 'pancreatic cancer' and 97 as 'non-neoplastic pancreatic lesion'. Consequently, for the detection of malignant tumours, the sensitivity was 97.0% (95.0% CI 88.7–99.5%) and the specificity was 81.5% (95.0% CI 73.1–87.8%). The prevalence of mutations was highest in pancreatic cancer; in the control group, mutations were found in approximately 35% of cases. CONCLUSION: A classifier based on a set of six miRNAs (miRNA-375, -143, -155, -96, -221, let-7a) may prove to be a promising additional tool for improving the quality and accuracy of the diagnosis of cytology samples from fine-needle aspiration biopsies of pancreatic neoplasms.
Zitieren
APA
Poloz, T. L., Titov, S. E., Anishchenko, V. V., Mirer, Y. A., Izupova, N. Y., Trakhanov, I. V., & Nasonova, E. N. (2026). Molecular genetic markers of pancreatic cancer in fine-needle biopsy samples. Journal of Clinical Practice, 17(3), 89-98. https://doi.org/10.17816/clinpract707917
Vancouver
Poloz TL, Titov SE, Anishchenko VV, Mirer YA, Izupova NY, Trakhanov IV, et al. Molecular genetic markers of pancreatic cancer in fine-needle biopsy samples. Journal of Clinical Practice. 2026;17(3):89-98. doi:10.17816/clinpract707917
BibTeX
@article{Poloz2026,
author = {Poloz, Tatiana L. and Titov, Sergey E. and Anishchenko, Vladimir Vladimirovich and Mirer, Yuliya A. and Izupova, Natalya Y. and Trakhanov, Ivan Vasilyevich and Nasonova, Ekaterina N.},
title = {Molecular genetic markers of pancreatic cancer in fine-needle biopsy samples},
journal = {Journal of Clinical Practice},
year = {2026},
volume = {17},
number = {3},
pages = {89--98},
doi = {10.17816/clinpract707917}
}
EUVIMED